Delivery Order SPE2DB20D9127-SPE2DB25FPQJ0
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,928.72 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The delivery order, which is set to be completed by July 22, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84-count units). This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,316.57 by the Defense Logistics Agency on September 26, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets (14-count). This delivery order represents one of numerous pharmaceutical product deliveries issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency,...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $18,488.12 for Trikafta 100-50-75 mg/150 mg oral units (84-count). This firm fixed-price delivery order, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a direct fulfillment of pharmaceutical supply needs under the company's existing Indefinite Delivery Contract with DLA. The award...
- The Defense Logistics Agency (DLA) awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg, a cystic fibrosis treatment medication. The delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a targeted pharmaceutical procurement without set-aside designation. DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Issued on November 6, 2025, with an ultimate completion date of November 7, 2025, this firm fixed-price delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on October 27, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $18,868.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order represents one of numerous purchase orders...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,758.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on September 29, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units, with a completion date of September 30, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a $18,488.12 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, operates under DMS Pharmaceutical Group's larger $499.999 billion Indefinite Delivery Contract with the Defense...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPQJ0Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,316.57 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, calls for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This award was issued without a set-aside designation, allowing the vendor to compete on an open basis leveraging its established capabilities in the federal pharmaceutical supply market. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. As a crucial supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites nationwide. The company's extensive portfolio includes branded and generic prescription drugs, biologics, and medical consumables, positioning it as a primary source for pharmaceutical products supporting military health facility requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 4/24/25 |